drugset / Trial / NCT04683029
A Study of Guselkumab in Participants With Systemic Sclerosis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of the study is to evaluate the efficacy of guselkumab in participants with systemic sclerosis (SSc).
Timeline
- Start
- 2021-02-24
- Primary completion
- 2023-05-17
- Completion
- 2024-07-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Guselkumab | Monoclonal antibody | — | Intravenous |